Monday, June 2, 2025
  • Login
Euro Times
No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology
Euro Times
No Result
View All Result

Gavi rejects Novavax’s claim on COVID vaccine deal breach By Reuters

by Reuters
November 22, 2022
in Stock Market
Reading Time: 2 mins read
A A
0
Home Stock Market
Share on FacebookShare on Twitter


© Reuters. FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

(Reuters) – Global vaccine alliance Gavi on Tuesday rejected Novavax (NASDAQ:)’s claim that the group had breached an advance purchase agreement to procure 350 million doses of the company’s COVID-19 vaccine.

Novavax said on Monday that it had issued a notice to Gavi for terminating the agreement with immediate effect, citing the alliance’s failure to procure the doses it had agreed to buy in May last year for the COVAX facility, a global vaccine distribution program.

The company’s shares were down nearly 9% in afternoon trade.

“It is clear that Novavax will not be able to meet its commitment to manufacture” the doses under the agreement for COVAX before the end of 2022, a Gavi spokesperson told Reuters.

More than 18 months after signing the agreement, Novavax has not been able to make a single dose available to COVAX from the contractually stipulated sites to-date, Gavi said.

Gavi added that it reserved all rights, including the recovery of advance payments to the company.

Novavax received a non-refundable advance payment of $350 million from Gavi last year and an additional $350 million this year after the vaccine got the World Health Organization’s emergency use listing.

In response to Gavi’s statement, the company reiterated that it has been ready to meet its commitment to manufacture and deliver doses for the COVAX facility.

Novavax also has a pact with Serum Institute of India for manufacturing a version of the vaccine under the brand Covovax, which would also be supplied to the COVAX facility.

Gavi’s spokesperson said Serum Institute had a 300 million dose commitment for Covovax, with options for 750 million more doses if needed.

A spokesperson for Serum Institute declined to comment.

Novavax recently cut its full-year forecast yet again, hurt by late authorizations of its COVID vaccine globally amid a waning demand for shots.



Source link

Tags: breachclaimCoviddealGaviNovavaxsrejectsReutersVaccine
Previous Post

Michigan House Speaker Sneers at Election Integrity Legislators, Refuses 2022 Voter Fraud Investigation

Next Post

Findings From Franklin Templeton’s RIA Technology Report: Elevating The Digital Client Experience

Related Posts

NetApp, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:NTAP)

NetApp, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:NTAP)

by SA Transcripts
June 2, 2025
0

This fall: 2025-05-29 Earnings AbstractEPS of $1.93 beats by $0.03  | Income of $1.73B (3.84% Y/Y) beats by $10.17MThis text was...

Limbach Holdings Stock: Growth Is Great, But Valuation Is A Concern (NASDAQ:LMB)

Limbach Holdings Stock: Growth Is Great, But Valuation Is A Concern (NASDAQ:LMB)

by David Zanoni
June 2, 2025
0

This text was written byObserveDavid focuses on development & momentum shares which can be moderately priced and prone to outperform...

Gibraltar Industries: Shares Have Fallen Enough To Justify An Upgrade (NASDAQ:ROCK)

Gibraltar Industries: Shares Have Fallen Enough To Justify An Upgrade (NASDAQ:ROCK)

by Daniel Jones
June 1, 2025
0

This text was written byObserveDaniel is an avid and energetic skilled investor. He runs Crude Worth Insights, a value-oriented publication...

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma (NASDAQ:CPRX)

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma (NASDAQ:CPRX)

by Out of Ignorance
May 31, 2025
0

This text was written byObserveWriting beneath the pseudonym "out of ignorance", I very a lot regard investing as a studying...

Dividend Champion, Contender, And Challenger Highlights: Week Of June 1

Dividend Champion, Contender, And Challenger Highlights: Week Of June 1

by Index Investing News
May 31, 2025
0

This textual content was written by Justin Laws has a Ph.D in Chemistry from Rice Faculty and has earned the...

John Hancock Income Fund Q1 2025 Commentary (JHFIX)

John Hancock Income Fund Q1 2025 Commentary (JHFIX)

by John Hancock Investment Management
May 31, 2025
0

This text was written byObserveAn organization of Manulife Funding Administration, John Hancock Funding Administration serves traders via a singular multimanager...

Next Post
Findings From Franklin Templeton’s RIA Technology Report: Elevating The Digital Client Experience

Findings From Franklin Templeton's RIA Technology Report: Elevating The Digital Client Experience

Abercrombie & Fitch, Disney, Best Buy, Zoom and more

Abercrombie & Fitch, Disney, Best Buy, Zoom and more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Costco Wholesale sees 8% net sales increase in Q3 FY25

Costco Wholesale sees 8% net sales increase in Q3 FY25

June 2, 2025
Outrage in Kenya over detention of software developer

Outrage in Kenya over detention of software developer

June 2, 2025
How Many Carbs Should You Eat Daily for Weight Loss?

How Many Carbs Should You Eat Daily for Weight Loss?

June 2, 2025
NetApp, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:NTAP)

NetApp, Inc. 2025 Q4 – Results – Earnings Call Presentation (NASDAQ:NTAP)

June 2, 2025
Shiba Inu Crash To Calm – Is SHIB Forming A Base Below?

Shiba Inu Crash To Calm – Is SHIB Forming A Base Below?

June 2, 2025
An Orb by Delivery: World Launches at-Home Iris Scanning in Argentina

An Orb by Delivery: World Launches at-Home Iris Scanning in Argentina

June 2, 2025
Euro Times

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Finance
  • Health
  • Investing
  • Markets
  • Politics
  • Stock Market
  • Technology
  • Uncategorized
  • World

LATEST UPDATES

Costco Wholesale sees 8% net sales increase in Q3 FY25

Outrage in Kenya over detention of software developer

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Finance
  • Business
  • World
  • Politics
  • Markets
  • Stock Market
  • Cryptocurrency
  • Investing
  • Health
  • Technology

Copyright © 2022 - Euro Times.
Euro Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In